130 related articles for article (PubMed ID: 3905210)
1. Effect of bromocriptine treatment on prolactin, noradrenaline and blood pressure in hypertensive haemodialysis patients.
Degli Esposti E; Sturani A; Santoro A; Zuccalà A; Chiarini C; Zucchelli P
Clin Sci (Lond); 1985 Jul; 69(1):51-6. PubMed ID: 3905210
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic control of sympathetic activity and blood pressure in haemodialysis patients.
Sturani A; Degli Esposti E; De March A; Santoro A; Fuschini G; Zuccalà A; Chiarini C; Flamigni C; Zucchelli P
Proc Eur Dial Transplant Assoc; 1983; 20():156-60. PubMed ID: 6657650
[TBL] [Abstract][Full Text] [Related]
3. [Hemodynamic and biological effects of bromocriptine in essential hypertension].
Allain H; Daubert JC; Massart C; van den Driessche J; Gouffault J
Arch Mal Coeur Vaiss; 1982 Sep; 75(9):951-62. PubMed ID: 6816179
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
Nagahama S; Chen YF; Oparil S
J Pharmacol Exp Ther; 1984 Feb; 228(2):370-5. PubMed ID: 6363675
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy.
Jungmann E; Haak T; Althoff PH; Fassbinder W; Schöffling K
Arzneimittelforschung; 1988 Feb; 38(2):296-300. PubMed ID: 3285838
[TBL] [Abstract][Full Text] [Related]
6. Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.
Schoeppe W; Brecht HM
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6994788
[TBL] [Abstract][Full Text] [Related]
7. Plasma prolactin, renin and catecholamines in young normotensive and borderline hypertensive subjects.
Saito I; Takeshita E; Saruta T; Nagano S; Sekihara T
J Hypertens; 1984 Feb; 2(1):61-4. PubMed ID: 6397523
[TBL] [Abstract][Full Text] [Related]
8. [Raised plasma-prolactin levels in essential hypertension: index of reduced hypothalamic dopaminergic activity (author's transl)].
Kolloch R; Stumpe KO; Higuchi M; Vetter H; Krück F
Klin Wochenschr; 1977 Oct; 55(20):1013-8. PubMed ID: 926711
[TBL] [Abstract][Full Text] [Related]
9. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
[TBL] [Abstract][Full Text] [Related]
10. Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control.
Stumpe KO; Kolloch R; Higuchi M; Krück F; Vetter H
Lancet; 1977 Jul; 2(8031):211-4. PubMed ID: 69827
[TBL] [Abstract][Full Text] [Related]
11. Bromocriptine in the treatment of hypertension.
Walden RJ; Hernandez J; Bhattacharjee P; Graham B; Prichard BN
Eur J Clin Pharmacol; 1986; 30(2):141-4. PubMed ID: 3519242
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic control of prolactin and blood pressure: altered control in essential hypertension.
Sowers JR; Nyby M; Jasberg K
Hypertension; 1982; 4(3):431-7. PubMed ID: 7068198
[No Abstract] [Full Text] [Related]
13. [Effect of bromocriptine on arterial blood pressure and serum prolactin level in patients with essential arterial hypertension].
Hudziak G; Kuska J
Kardiol Pol; 1988; 31 Suppl 1():22-9. PubMed ID: 3221620
[No Abstract] [Full Text] [Related]
14. Adrenergic and dopaminergic regulation of circulating beta-endorphin-like immunoreactivity in hypertension.
Alföldi A; Simkó K; Fekete MI; Farsang C
Acta Physiol Hung; 1991; 78(1):99-106. PubMed ID: 1763654
[TBL] [Abstract][Full Text] [Related]
15. The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension.
Vandenburg MJ; Holly JM; Goodwin FJ; Sharman VL; Marsh FP
Eur J Clin Pharmacol; 1983; 25(6):721-8. PubMed ID: 6319152
[TBL] [Abstract][Full Text] [Related]
16. Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release.
Mannelli M; Delitala G; De Feo ML; Maggi M; Cuomo S; Piazzini M; Guazzelli R; Serio M
J Clin Endocrinol Metab; 1984 Jul; 59(1):74-8. PubMed ID: 6725527
[TBL] [Abstract][Full Text] [Related]
17. Bromocriptine reduces plasma noradrenaline and 3,4-dihydroxyphenylacetic acid in normal and hypotensive subjects.
Mercuro G; Rossetti ZL; Tocco L; Rivano CA; Cherchi A; Gessa GL
Eur J Clin Pharmacol; 1985; 27(6):671-5. PubMed ID: 3987772
[TBL] [Abstract][Full Text] [Related]
18. Effects of bromocriptine on responses to stress in spontaneously hypertensive rats.
Sowers JR
Hypertension; 1981; 3(5):544-50. PubMed ID: 7028608
[TBL] [Abstract][Full Text] [Related]
19. The effects of bromocriptine in methyldopa treated hypertension.
Lewis MJ; Henderson AH
Br J Clin Pharmacol; 1980 Jan; 9(1):57-60. PubMed ID: 6986893
[TBL] [Abstract][Full Text] [Related]
20. Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients.
Luchsinger A; Grilli M; Forte P; Morales E; Velasco M
Int J Clin Pharmacol Ther; 1995 Sep; 33(9):509-12. PubMed ID: 8520809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
